top of page
Tarceva is a prescription tyrosine kinase inhibitor (TKI) used for the treatment of certain types of cancers. It should only be prescribed by a provider specialized in the treatment of cancer. Tarceva can treat certain types of non-small cell lung cancer (NSCLC) cancer and pancreatic cancer. It is commonly used along with other drugs. Fact Table Formula C22H23N3O4 License US FDA, EU EMA Bioavailability 59% Legal status Rx-only Chemical Name Erlotinib Elimination half-life 36.2 hrs Dosage (Strength) 25mg Pregnancy Not Recommended Brands Tarceva Protein binding 95% PubChem CID 176870 MedlinePlus a605008 ChEBI 114785 ATC code L01EB02 DrugBank DB00530 KEGG D07907 Routes of administration By mouth

Tarceva (Erlotinib)

  • Take Tarceva exactly as prescribed. This drug should be taken on an empty stomach one hour before or two hours after meals.
bottom of page